|
|
Article: A randomized, double-blind, placebo-controlled, clinical dose-response trial of an extract of Baptisia, Echinacea and Thuja for the treatment of patients with common cold.
- Article from:
- Phytomedicine: International Journal of Phytotherapy & Phytopharmacology
- Article date:
- November 1, 2005
- Author:
CopyrightCOPYRIGHT 2005 Urban & Fischer Verlag. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Abstract
The aim of this study was to verify the efficacy and safety of an herbal medication containing an extract of a mixture of Baptisiae tinctoriae radix, Echinaceae pallidae/purpureae radix and Thujae occidentalis herba (SB-TOX) in the treatment of upper respiratory tract infections (URIs), and to test whether SB-TOX's clinical efficacy is dose dependent. A total of 91 adults (mean age 42.1 [+ or -] 13.0 years) were randomised to receive 19.2 mg of SB-TOX (n = 31), 9.6 mg SB-TOX (n = 29) or placebo (n = 31) three times daily for 3-12 days. Since a "running nose" is the main symptom of a common cold, the total number of facial tissues used throughout the ...
Related newspaper, magazine, and journal articles:
|
|
Transcript: Interview: Jill Uris on the life of writer Leon ...
NPR All Things Considered;
June 24, 2003 ;
700+ words
...00-00-0000 Interview: Jill Uris on the life of writer Leon Uris Host: MICHELE NORRIS Time: 9:00-10:00 PM MICHELE NORRIS, host: Author Leon Uris has died. He wrote best-selling historical novels that ...
|
|